{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:25:04Z","timestamp":1787131504833,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,25]],"date-time":"2027-02-25T00:00:00Z","timestamp":1803513600000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"The Welch Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114730","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T23:34:50Z","timestamp":1771198490000},"page":"114730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A multidomain peptide hydrogel-liposome composite for controlled release of a cyclic dinucleotide in oral cancer"],"prefix":"10.1016","volume":"392","author":[{"given":"Joseph W.R.","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemalene M.","family":"Sunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Chew-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraja","family":"Dharmaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Cobos","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghadip","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim J.","family":"V\u00e1zquez-Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Hartgerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114730_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155489","article-title":"Comprehensive insights into Oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances","volume":"261","author":"Jagadeesan","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"33","key":"10.1016\/j.jconrel.2026.114730_bb0010","doi-asserted-by":"crossref","first-page":"55600","DOI":"10.18632\/oncotarget.16340","article-title":"Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114730_bb0015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of treatment failure and Postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques","volume":"3","author":"Leeman","year":"2017","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114730_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114730_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114730_bb0030","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","article-title":"Understanding and treating the inflammatory adverse events of cancer immunotherapy","volume":"184","author":"Dougan","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114730_bb0035","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1080\/21645515.2015.1129478","article-title":"Ipilimumab (anti-Ctla-4 mab) in the treatment of metastatic melanoma: effectiveness and toxicity management","volume":"12","author":"Savoia","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114730_bb0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114730_bb0045","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/1078-0432.CCR-21-0426","article-title":"Phase I trial of cetuximab, radiotherapy, and ipilimumab in locally advanced head and neck cancer","volume":"28","author":"Ferris","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114730_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10555-017-9694-9","article-title":"Checkpoint immunotherapy in head and neck cancers","volume":"36","author":"Zolkind","year":"2017","journal-title":"Cancer Metastasis Rev."},{"issue":"7370","key":"10.1016\/j.jconrel.2026.114730_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic Di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"issue":"6121","key":"10.1016\/j.jconrel.2026.114730_bb0060","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"6121","key":"10.1016\/j.jconrel.2026.114730_bb0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114730_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an Intratumoral STING agonist, in patients with advanced\/metastatic solid Tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114730_bb0075","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.actamat.2012.10.046","article-title":"Self-assembly for the synthesis of functional biomaterials","volume":"61","author":"Stephanopoulos","year":"2013","journal-title":"Acta Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114730_bb0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41563-018-0147-9","article-title":"Biomaterial-assisted targeted modulation of immune cells in cancer treatment","volume":"17","author":"Wang","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.114730_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1139782","article-title":"Self-assembling peptides as immunomodulatory biomaterials","volume":"11","author":"Hernandez","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114730_bb0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/ten.tec.2023.0090","article-title":"Enhancement of immunotherapies in head and neck cancers using biomaterial-based treatment strategies","volume":"29","author":"Sunga","year":"2023","journal-title":"Tissue Eng. Part C Methods"},{"issue":"41","key":"10.1016\/j.jconrel.2026.114730_bb0095","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1021\/ja072536r","article-title":"Self-assembly of multidomain peptides: balancing molecular frustration controls conformation and nanostructure","volume":"129","author":"Dong","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114730_bb0100","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1021\/bm900634x","article-title":"Self-assembly of multidomain peptides: sequence variation allows control over cross-linking and viscoelasticity","volume":"10","author":"Aulisa","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114730_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119667","article-title":"Chemical functionality of multidomain peptide hydrogels governs early host immune response","volume":"231","author":"Lopez-Silva","year":"2020","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114730_bb0110","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/acsbiomaterials.3c01617","article-title":"Nanofibrous MultiDomain peptide hydrogels provide T cells a 3D, cytocompatible environment for cell expansion and antigen-specific killing","volume":"10","author":"Leyva-Aranda","year":"2024","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.114730_bb0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biomaterials.2018.01.035","article-title":"STINGel: controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy","volume":"163","author":"Leach","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114730_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114588","article-title":"Nanoengineering of cyclic dinucleotide-manganese complexes using biodegradable mesoporous silica nanoparticles for cancer Metallo-immunotherapy","volume":"390","author":"Rana","year":"2026","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.114730_bb0125","article-title":"Liposomal delivery enhances immune activation by STING agonists for cancer immunotherapy","volume":"1","author":"Koshy","year":"2017","journal-title":"Adv. Biosys."},{"key":"10.1016\/j.jconrel.2026.114730_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2014.04.004","article-title":"A new adjuvant delivery system \u2018cyclic Di-GMP\/YSK05 liposome\u2019 for cancer immunotherapy","volume":"184","author":"Miyabe","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114730_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2015.08.026","article-title":"Liposomes loaded with a STING pathway ligand, cyclic Di-GMP, enhance cancer immunotherapy against metastatic melanoma","volume":"216","author":"Nakamura","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114730_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"46","key":"10.1016\/j.jconrel.2026.114730_bb0145","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1002\/anie.201806483","article-title":"Design of a multicompartment hydrogel that facilitates time-resolved delivery of combination therapy and synergized killing of glioblastoma","volume":"57","author":"Majumder","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114730_bb0150","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1021\/acs.biomac.3c00664","article-title":"Orthogonal self-assembly of amphiphilic peptide hydrogels and liposomes results in composite materials with Tunable release profiles","volume":"24","author":"Swain","year":"2023","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114730_bb0155","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s42003-022-03675-4","article-title":"Mutant P53 drives an immune cold tumor immune microenvironment in Oral squamous cell carcinoma","volume":"5","author":"Shi","year":"2022","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114730_bb0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/pharmaceutics15020638","article-title":"Liposomal delivery of MIW815 (ADU-S100) for potentiated STING activation","volume":"15","author":"Ji","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114730_bb0165","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.matt.2022.03.001","article-title":"Injectable liposome-based supramolecular hydrogels for the programmable release of multiple protein drugs","volume":"5","author":"Correa","year":"2022","journal-title":"Matter"},{"key":"10.1016\/j.jconrel.2026.114730_bb0170","article-title":"Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: a comprehensive review of strategies and future perspectives","volume":"23","author":"Huang","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114730_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.11.047","article-title":"Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity","volume":"25","author":"Sivick","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114730_bb0180","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jconrel.2024.03.022","article-title":"STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid Leukemia","volume":"368","author":"Aikins","year":"2024","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:31:40Z","timestamp":1787128300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592600132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"alternative-id":["S016836592600132X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114730","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multidomain peptide hydrogel-liposome composite for controlled release of a cyclic dinucleotide in oral cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114730"}}